SCHEMBL12612347

SCHEMBL12612347

CN1CCCOC(C)(C)C1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12612290 0.75 BRD4 (0.37) —
SCHEMBL17345852 0.61 LMNA (0.37) —
SCHEMBL18124965 0.61 — —
SCHEMBL14428798 0.58 INMT (0.39) —
SCHEMBL21505052 0.58 — —
SCHEMBL19217076 0.58 KMT2A (0.32) —
SCHEMBL14467775 0.58 — —
SCHEMBL21505049 0.56 — —
SCHEMBL208037 0.56 — —
SCHEMBL18183422 0.56 INMT (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2686307-A1 1,4-OXAZEPINES AS BACE1 AND/OR BACE2 INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-01-22 — — EP disclosed
WO-2012126791-A1 1,4-OXAZEPINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-09-27 — — WO disclosed
Send feedback